GPT Healthcare IPO Details Launch Date, share price, Issue Size, GMP Price, Review

GPT Healthcare ipo

Overview

We are one of the key regional corporate healthcare companies in Eastern India in terms of several beds and hospitals as of Fiscal Year 2023. We operate a chain of mid-sized full-service multi-specialty hospitals in Eastern India under the brand and provide integrated healthcare services, with a focus on secondary and tertiary care. As of June 30, 2023, we operate four full-service multispecialty hospitals, with a total capacity of 561 beds.

We strategically focus on the relatively under-penetrated healthcare market in Eastern India where we have a presence in three cities which we believe has provided an understanding of regional nuances, patient culture, and the mindset of medical professionals and where there is under-penetration of quality and affordable healthcare services.

This has enabled our Company to deliver robust financial performance, with our revenue from operations (ex-COVID) growing at a CAGR of 53.87% over Fiscal Year 2021 to Fiscal Year 2023 and ROCE being 26.09% for Fiscal Year 2023.

OBJECTS OF THE OFFER

The Offer comprises a Fresh Issue of up to [●] Equity Shares aggregating up to ₹ 400.00million and an Offer for Sale of up to 26,082,786 Equity Shares aggregating up to ₹ [●] million by the Investor Selling Shareholder.

GPT Healthcare Company Financial Report

Rupees in Crores
IncomeExpensePAT
2019₹175₹154₹14.95
2020₹216₹201₹10.96
2021₹249₹220₹21.09
2022-3M₹92₹72₹16.16

Offer for Sale

The proceeds of the Offer for Sale shall be received by the Investor Selling Shareholder and will not form part of the Net Proceeds. Our Company will not receive any proceeds from the Offer for Sale. The Investor Selling Shareholder will be entitled to the proceeds from the Offer for Sale, after deducting their share of the Offer-related expenses and relevant taxes thereon.

Fresh Issue

Requirement of funds

Our Company proposes to utilize the Net Proceeds towards funding the following objects:

  1.  Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company from banks and financial institutions.
  2.  General corporate purposes.

Our Promoters

GPT Sons Private Limited, Dwarika Prasad Tantia,Dr. Om Tantia and Shree Gopal Tantia are the Promoters of our Company.

Name of the Director Designation in GPT Sons Private Limited 
Dwarika Prasad Tantia Chairman
Dr. Om Tantia Director
Shree Gopal TaniaDirector

Qualitative Factors

We believe that some of the qualitative factors that form the basis for computing the Offer Price are as follows:

  1. Key regional corporate healthcare company with a strong foothold in under-penetrated and densely populated healthcare delivery markets.
  2. Right-sized, full-service, and strategically located hospitals lead to high returns on capital.
  3. Well-diversified specialty mix and location mix.
  4. Ability to attract, train, and retain quality medical professionals.
  5. Track record of operating and financial performance and growth.
  6. Professional management and experienced leadership.
  7. Investment in infrastructure, processes, and clinical excellence driving affordability, and a strong value proposition for stakeholders.

GPT Healthcare IPO Lead Managers

  • DAM Capital Advisors Limited
  • SBI Capital Markets Limited

GPT Healthcare IPO Registar

Link Intime India Private Limited
C-101, 247 Park,
Lal Bahadur Shastri Marg, Vikhroli(West),
Mumbai 400 083Maharashtra,
IndiaTel: +91 22 810 811 4949
E-mail: gpthealthcare.ipo@linkintime.co.in
Investor grievance E-mail: gpthealthcare.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact Person: Shanti Gopalkrishnan

GPT Healthcare Company Details

GPT Healthcare Limited
GPT Centre, JC –25, Sector III
Salt Lake, Kolkata 700 106,
West Bengal, India
Tel:+ (91) 33 4050 7000
E-mail:ghl.cosec@gptgroup.co.in
Website:www.ilshospitals.com

Leave a Comment

Facebook
Twitter
WhatsApp
Telegram
LinkedIn